Cost the baseline before enrollment: the annual study-management fee standalone sites quietly absorb

Most site budgets are built around the visit. Each procedure, each visit and each patient gets a line, and the budget is negotiated from there. But a study creates work for your site every month it is open, whether or not a patient walks through the door that month. Check whether your budgets explicitly cover that work, or rely on per-visit overhead to recover it.

At a standalone site without a larger institution behind it, that ongoing work is easy to absorb into overhead without anyone deciding to. Across a portfolio of studies, it can decide whether research pays for itself. The fix starts with naming it: an annual study-management baseline, separate from the study-specific costs you already price. Many sponsor budget templates already have a line for this, often called an annual maintenance, administrative or regulatory upkeep fee. Use the term the sponsor's template uses, and make sure the amount reflects your real costs.

What the baseline includes

The baseline is the ongoing work and systems needed to keep a study open and inspection-ready for a year. Typical items include:

• Regulatory maintenance. Maintaining essential records; reviewing and submitting amendments and safety information as applicable; completing required IRB continuing review or status reports (FDA-regulated studies still need continuing review at least once a year); and keeping delegation logs, Form FDA 1572, CVs, licenses and investigator financial disclosures current as staff change. IRB fees themselves are usually a separate pass-through line.
• Investigational product management. For studies with investigational product: qualified staff oversight, receipt, secure storage, accountability, reconciliation and authorized return or destruction, with pharmacy involvement where required. Include quarantine and documented handling of stock affected by a temperature excursion.
• Temperature monitoring. Monitoring the required storage conditions, reviewing records and alarms, keeping equipment calibrated, and arranging excursion response and backup storage, including after-hours coverage where needed. The frequency and method come from product requirements, study instructions and your own procedures.
• Kit and supply storage. Space for lab kits, ancillary supplies and study materials, tracking expiry dates, and managing resupply.
• Systems. An allocated share of the clinical trial management system (CTMS), eSource and eRegulatory (eREG) platforms your site actually uses, including access administration, support and record retention, plus the ongoing time to keep each study current in them. Sponsor systems add their own logins and training.
• Training. Protocol training for new staff, refresher training after amendments, GCP refreshers required by the sponsor or your site's policy, and system-specific training sponsors require.
• Monitoring support. Preparing for and hosting monitoring visits, answering queries and resolving action items, whether or not patients were seen that period. If you already bill monitoring visits per visit, leave them out of the baseline.

Some of these costs continue with no enrollment at all. Others grow with participants, visits, product handling, amendments and data queries. The baseline is the part that stays even when enrollment is slow.

Two lifecycle items are worth pricing on their own, unless your budget expressly includes them: study start-up, including initial system setup, and close-out, including final reconciliation, the close-out visit, and record retention, retrieval and continued electronic access for the regulatory and contractual retention periods.

Why it gets absorbed

There are a few common reasons this work never reaches a budget:

• It is shared. One coordinator maintains several binders, and one temperature system covers every study. Shared costs are easy to leave out of any single budget.
• It is invisible to the sponsor. Sponsors and CROs see visits and data. They rarely see the hours behind a clean regulatory binder.
• Start-up fees cover the beginning, not the middle. A site may negotiate a start-up fee, then nothing for the time the study stays open.
• Slow-enrolling studies hide it. When a study enrolls fewer patients than planned, per-visit revenue falls but much of the ongoing work stays.

How to separate the baseline from study-specific costs

Build your rate card in two layers.

Layer 1: the annual study-management baseline. Estimate the yearly cost of keeping one study open: staff hours for regulatory upkeep, investigational product management, temperature monitoring and monitoring-visit support, plus an allocated share of systems, storage and training. Use your own time records and invoices. If you don't track time by study today, track it for a few months on a sample of studies. Use the estimate to propose an annual fee, or quarterly installments, for defined ongoing work. The signed clinical trial agreement and budget must set the amount, the period it covers and the payment conditions, including periods without enrollment. Check how it fits with your overhead (indirect) rate: if overhead already covers systems, storage or general administration, don't charge for them again here.

Layer 2: study-specific costs. These are the items that change with the protocol and with enrollment: per-visit procedures, screen failures, unscheduled visits, protocol-specific training, special storage, extra pharmacy work for complex dosing, and amendments that add work. Price them per occurrence, as most sites already do.

Define what each fee covers, and remove any overlap with per-visit overhead, start-up fees, pharmacy charges and monitoring fees, so the same work is never charged twice. A sponsor may push back on a line item, but a clearly defined baseline is much easier to explain than an unexplained overhead percentage.

Practical steps for your next budget

1. List every recurring task your team does for an open study, and who does it.
2. Estimate hours per year for each task, per study, from your own records.
3. Allocate shared costs for systems, storage and training using a documented basis, such as storage space, users or staff time. An equal split can work when studies are similar.
4. Propose a baseline fee per study per year, invoiced annually or quarterly.
5. Add it to your standard rate card, so it appears in every budget from the first draft.
6. Write it into the clinical trial agreement and budget, including when the fee starts (for example, at site activation) and ends, invoice requirements, payment deadlines, extensions, pauses, early termination, proration and obligations after close-out.
7. Revisit it each year as your systems and staffing change.

Document the services, how you allocated costs and why the amount is commercially reasonable and consistent with fair market value. Your cost records support that explanation; they don't by themselves settle fair market value or legal questions, so involve your own advisers where needed.

Where Shortlisted™ fits

A clear rate card helps you explain your costs during budget discussions. In the free Sponsor-Ready Audit, we look at how your site presents itself to sponsors and CROs, and in the 6-Month Site Pilot we help you put together a one-page proof sheet of your capabilities. Shortlisted™ is pay-on-success: no setup fee, no monthly retainer, and a fixed fee only when a qualified feasibility arrives. We don't set your budgets or negotiate them for you; those stay with your team.

The short version

Every open study carries ongoing work that doesn't wait for enrollment. Name it, measure it, propose it as an annual study-management baseline, and keep it separate from study-specific costs. Explicit pricing can reduce the ongoing study costs your site absorbs.

FAQ